Skip to main content

No Signs Of Settlements In The Ongoing Xarelto Litigation

No Signs Of Settlements In The Ongoing Xarelto Litigation

No Signs Of Settlements In The Ongoing Xarelto Litigation

Introduction

No signs of settlements in the ongoing Xarelto Litigation currently underway in the Eastern District of Louisiana, leads U. S. District Judge Eldon Fallon to order two separate waves of lawsuits, each comprising 600 cases totaling to 1,200 lawsuits to be prepared for trial. These additional cases will go through case-specific discovery. The first wave requires the plaintiffs and defendants to pick their 200 cases each until April 16, 2018, and the court will make its random selections on April 30. Similarly, for the second wave, August 16 is set for the plaintiffs and defendants to submit their pick of cases to undergo a discovery process and August 30 for the court to make its random selections.

Bayer and Johnson & Johnson's Janssen division are facing more than 18,000 cases nationwide wherein each allegation points that users and the medical community were not adequately warned about the risk of uncontrollable bleeding on Xarelto.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!